Fulminant Mantle Cell Lymphoma Presenting With Hepatic Infiltration and Spontaneous Tumor Lysis Syndrome. [PDF]
Sheth S, Alsamman A.
europepmc +1 more source
Evolving therapeutic strategies in mantle cell lymphoma: advancements and future directions. [PDF]
Tavarozzi R +7 more
europepmc +1 more source
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee. [PDF]
Dreger P +14 more
europepmc +1 more source
Relapse as a return, not a reinvention - genomic stability and pre-existing resistance in mantle cell lymphoma. [PDF]
Pott C.
europepmc +1 more source
Transforming mantle cell lymphoma: the journey across eras. [PDF]
Castonguay M, Seymour JF.
europepmc +1 more source
Response alone does not define optimal bridging before brexucabtagene autoleucel in mantle cell lymphoma. [PDF]
Zhang M, Chen Y.
europepmc +1 more source
Eprenetapopt in combination with Palbociclib exerts synthetic lethality in mantle cell lymphoma. [PDF]
Dong L +9 more
europepmc +1 more source
CAR T-cell vs bispecific antibodies in relapsed/refractory mantle cell lymphoma: a systematic review and meta-analysis. [PDF]
Li MJ +9 more
europepmc +1 more source
Full-house nephropathy associated with mantle cell lymphoma. [PDF]
Kinoshita K, Koga K, Yahata K.
europepmc +1 more source
Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score-Matched Real-World Analysis. [PDF]
Homeniuk A +3 more
europepmc +1 more source

